Using next generation sequencing to guide treatment of co-existing T-cell lymphoma and chronic myelomonocytic leukemia

Leuk Lymphoma. 2023 May;64(5):1045-1049. doi: 10.1080/10428194.2023.2192316. Epub 2023 Mar 24.

Authors

Ross T Salvaris^{1

2}, Benjamin Allanson³, Chan Y Cheah^{1

2}

Affiliations

¹ Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia.
² School of Medicine, University of Western Australia, Perth, Australia.
³ Department of Anatomical Pathology, PathWest, Queen Elizabeth II Medical Centre, Nedlands, Australia.

PMID: 36961966
DOI: 10.1080/10428194.2023.2192316

No abstract available

Publication types

Letter

MeSH terms

High-Throughput Nucleotide Sequencing
Humans
Leukemia, Myelomonocytic, Chronic* / diagnosis
Leukemia, Myelomonocytic, Chronic* / drug therapy
Leukemia, Myelomonocytic, Chronic* / genetics
Lymphoma, T-Cell* / pathology
Lymphoma, T-Cell, Peripheral*